Table 4. Patients and tumor characteristics.

Variable	Value (%)
Age at diagnosis (year)
Median	54.9
<50	50 (25.4)
50–65	82 (41.6)
>65	65 (33.0)
Menopausal status
Pre/perimenopausal	70 (35.5)
Postmenopausal	127 (64.5)
Tumor size
⩽2 cm	127 (64.5)
>2 cm	70 (35.5)
Molecular subtypes
Luminal-A	80 (40.6)
Luminal-B/HER-2-negative	53 (26.9)
Luminal-B/HER-2-positive	17 ( 8.6)
HER-2	13 ( 6.6)
Triple negative	34 (17.3)
Tumor grade
1	22 (11.2)
2–3	175 (88.8)
ER
Negative	56 (28.4)
Positive	141 (71.6)
PR
Negative	67 (34.0)
Positive	130 (66.0)
Ki-67
Low	103 (52.3)
High	94 (47.7)
HER-2
Negative	169 (85.8)
Positive	28 (14.2)
m-Nectin-4
Negative	163 (82.7)
Positive	34 (17.3)
c-Nectin-4
Low/Negative	41 (20.8)
High	122 (61.9)
Patient outcome
Without recurrence	146 (74.1)
Local recurrence	20 (10.2)
Distant recurrence	31 (15.7)